{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:05:07Z","timestamp":1777341907841,"version":"3.51.4"},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1K08GM117310-01A"],"award-info":[{"award-number":["1K08GM117310-01A"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ccc.2019.11.004","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T08:04:23Z","timestamp":1580457863000},"page":"333-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill"],"prefix":"10.1016","volume":"36","author":[{"given":"Carlos L.","family":"Manrique-Caballero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadudee","family":"Peerapornratana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra","family":"Formeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaspar","family":"Del Rio-Pertuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernando","family":"Gomez Danies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ccc.2019.11.004_bib1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccc.2019.11.004_bib2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"38\u201339","key":"10.1016\/j.ccc.2019.11.004_bib3","first-page":"905","article-title":"Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia","volume":"85","author":"Gasser","year":"1955","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.ccc.2019.11.004_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldl004","article-title":"Atypical haemolytic uraemic syndrome","volume":"77-78","author":"Kavanagh","year":"2006","journal-title":"Br Med Bull"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"10095","key":"10.1016\/j.ccc.2019.11.004_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.ccc.2019.11.004_bib9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"10.1016\/j.ccc.2019.11.004_bib10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1056\/NEJMoa1106482","article-title":"German outbreak of Escherichia coli O104:H4 associated with sprouts","volume":"365","author":"Buchholz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9464","key":"10.1016\/j.ccc.2019.11.004_bib11","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib12","doi-asserted-by":"crossref","first-page":"e59209","DOI":"10.1371\/journal.pone.0059209","article-title":"Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection","volume":"8","author":"Zoufaly","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ccc.2019.11.004_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13256-016-0970-z","article-title":"Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature","volume":"10","author":"Ko","year":"2016","journal-title":"J\u00a0Med Case Rep"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori","year":"2013","journal-title":"World J Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.ccc.2019.11.004_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ijlh.12671","article-title":"Diagnostic approach to microangiopathic hemolytic disorders","volume":"39","author":"Kottke-Marchant","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00431-015-2642-1","article-title":"Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network","volume":"175","author":"Ardissino","year":"2016","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.ccc.2019.11.004_bib17","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/644621","article-title":"Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006","volume":"49","author":"Gould","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.ccc.2019.11.004_bib18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","article-title":"Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany","volume":"365","author":"Frank","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib19","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1542\/peds.2004-2236","article-title":"Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion","volume":"115","author":"Ake","year":"2005","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.ccc.2019.11.004_bib20","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MOP.0b013e32835d7f2c","article-title":"Update on Streptococcus pneumoniae associated hemolytic uremic syndrome","volume":"25","author":"Spinale","year":"2013","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2007.03.055","article-title":"Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience","volume":"151","author":"Waters","year":"2007","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5414\/CN107205","article-title":"Thomsen-Friedenreich antigen exposure as a cause of Streptococcus pyogenes-associated hemolytic-uremic syndrome","volume":"78","author":"Shimizu","year":"2012","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2006-939767","article-title":"Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome","volume":"32","author":"Zimmerhackl","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/qjmed\/hcv082","article-title":"A\u00a0national specialized service in England for atypical haemolytic uraemic syndrome-the first year's experience","volume":"109","author":"Sheerin","year":"2016","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.ccc.2019.11.004_bib28","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","article-title":"An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome","volume":"29","author":"Johnson","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ccc.2019.11.004_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom","volume":"148","author":"Taylor","year":"2010","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ccc.2019.11.004_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/INF.0b013e31828b31c8","article-title":"Trends in US hospital stays for Streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"32","author":"Veesenmeyer","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/fpd.2014.1915","article-title":"Bacterial enteric infections among older adults in the United States: foodborne diseases active surveillance network, 1996-2012","volume":"12","author":"Scallan","year":"2015","journal-title":"Foodborne Pathog Dis"},{"issue":"8","key":"10.1016\/j.ccc.2019.11.004_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":"Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00467-014-2918-0","article-title":"Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome","volume":"30","author":"Ardissino","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document","volume":"35","author":"Campistol","year":"2015","journal-title":"Nefrologia"},{"issue":"11","key":"10.1016\/j.ccc.2019.11.004_bib36","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1515\/cclm-2015-0024","article-title":"Atypical hemolytic uremic syndrome: from diagnosis to treatment","volume":"53","author":"Franchini","year":"2015","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"10.1016\/j.ccc.2019.11.004_bib37","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"21","key":"10.1016\/j.ccc.2019.11.004_bib38","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1182\/blood-2016-11-743104","article-title":"None of the above: thrombotic microangiopathy beyond TTP and HUS","volume":"129","author":"Masias","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjh.14482","article-title":"How do we approach thrombocytopenia in critically ill patients?","volume":"177","author":"Thachil","year":"2017","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ajcp\/aqw195","article-title":"Disseminated intravascular coagulation","volume":"146","author":"Boral","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"21","key":"10.1016\/j.ccc.2019.11.004_bib41","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.pcl.2013.08.007","article-title":"HUS and TTP in children","volume":"60","author":"Trachtman","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"23","key":"10.1016\/j.ccc.2019.11.004_bib43","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib44","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ccc.2019.11.004_bib45","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1537-2995.2010.02653.x","article-title":"The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange","volume":"50","author":"Bentley","year":"2010","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib46","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/vox.12050","article-title":"Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort","volume":"105","author":"Bentley","year":"2013","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/jth.13882","article-title":"External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment","volume":"16","author":"Li","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"10.1016\/j.ccc.2019.11.004_bib49","first-page":"2","article-title":"Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis","volume":"14 Suppl 11","author":"Laurence","year":"2016","journal-title":"Clin Adv Hematol Oncol"},{"issue":"7","key":"10.1016\/j.ccc.2019.11.004_bib50","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1128\/JCM.02013-08","article-title":"Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture","volume":"47","author":"Grys","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib51","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1542\/peds.2007-2017","article-title":"Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A","volume":"125","author":"Copelovitch","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chest.2017.03.055","article-title":"Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome","volume":"152","author":"Azoulay","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ccc.2019.11.004_bib53","first-page":"5","article-title":"Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome","volume":"3","author":"Ohanian","year":"2011","journal-title":"Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7050137","article-title":"Shiga-toxin producing Escherichia coli in Brazil: a systematic review","volume":"7","author":"Castro","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.ccc.2019.11.004_bib55","series-title":"Public Health reporting and National Notification for Shiga toxin-producing Escherichia coli (STEC)","author":"Council of State and Territorial Epidemiologists","year":"2017"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pcl.2018.09.011","article-title":"Hemolytic uremic syndrome","volume":"66","author":"Cody","year":"2019","journal-title":"Pediatr Clin North Am"},{"issue":"10","key":"10.1016\/j.ccc.2019.11.004_bib57","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.ccc.2019.11.004_bib58","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1182\/blood-2011-06-363648","article-title":"Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MNH.0b013e328354a62e","article-title":"Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics","volume":"21","author":"Petruzziello-Pellegrini","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib61","first-page":"168","article-title":"The complement system in hemolytic-uremic syndrome in childhood","volume":"13","author":"Monnens","year":"1980","journal-title":"Clin Nephrol"},{"issue":"7","key":"10.1016\/j.ccc.2019.11.004_bib62","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2215\/CJN.08921209","article-title":"Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome","volume":"5","author":"Nathanson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib63","first-page":"441","article-title":"Hemolytic uremic syndrome in children","volume":"68","author":"Talarico","year":"2016","journal-title":"Minerva Pediatr"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","article-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","volume":"78","author":"Borowitz","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens Res"},{"issue":"10","key":"10.1016\/j.ccc.2019.11.004_bib66","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpediatrics.2011.152","article-title":"Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome","volume":"165","author":"Hickey","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","article-title":"Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"26","key":"10.1016\/j.ccc.2019.11.004_bib68","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections","volume":"342","author":"Wong","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tmrv.2016.06.004","article-title":"Clinical and laboratory consequences of platelet transfusion in shiga toxin-mediated hemolytic uremic syndrome","volume":"31","author":"Beneke","year":"2017","journal-title":"Transfus Med Rev"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00467-013-2414-y","article-title":"Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome","volume":"28","author":"Balestracci","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00467-014-2984-3","article-title":"Hemoconcentration in hemolytic uremic syndrome: time to review the standard case definition?","volume":"30","author":"Balestracci","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.ccc.2019.11.004_bib72","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00467-010-1530-1","article-title":"Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome","volume":"25","author":"Weil","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib73","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1744-9987.12768","article-title":"Is plasma exchange efficacious in shiga toxin-associated hemolytic uremic syndrome? A narrative review of current evidence","volume":"23","author":"Keenswijk","year":"2019","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ccc.2019.11.004_bib74","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ccc.2019.11.004_bib75","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","article-title":"Long-term outcomes of Shiga toxin hemolytic uremic syndrome","volume":"28","author":"Spinale","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib76","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s004670050248","article-title":"Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features","volume":"11","author":"Spizzirri","year":"1997","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib77","first-page":"352","article-title":"Hemolytic uremic syndrome: defining the need for long-term follow-up","volume":"52","author":"Small","year":"1999","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib78","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"Hemolytic uremic syndrome; pathogenesis, treatment, and outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00467-011-1973-z","article-title":"Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children","volume":"27","author":"Rahman","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"112","key":"10.1016\/j.ccc.2019.11.004_bib80","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1038\/ki.2008.619","article-title":"Relationship between Escherichia coli O157:H7 and diabetes mellitus","author":"Suri","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib81","first-page":"S3","article-title":"Central nervous system involvement in hemolytic uremic syndrome (HUS)--a retrospective analysis of cerebral CT and MRI studies","volume":"56","author":"Theobald","year":"2001","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5414\/CNP59196","article-title":"Late onset seizures, hemiparesis and blindness in hemolytic uremic syndrome","volume":"59","author":"Bennett","year":"2003","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1016\/j.ccc.2019.11.004_bib83","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00134-014-3630-z","article-title":"Understanding organ dysfunction in thrombotic thrombocytopenic purpura","volume":"41","author":"Mannucci","year":"2015","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib85","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib86","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/302877","article-title":"Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome","volume":"66","author":"Buddles","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"13","key":"10.1016\/j.ccc.2019.11.004_bib87","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ccc.2019.11.004_bib88","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/jmedgenet-2014-102498","article-title":"Factors determining penetrance in familial atypical haemolytic uraemic syndrome","volume":"51","author":"Sansbury","year":"2014","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib89","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpneph0018","article-title":"Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?","volume":"1","author":"Noris","year":"2005","journal-title":"Nat Clin Pract Nephrol"},{"issue":"8","key":"10.1016\/j.ccc.2019.11.004_bib90","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","article-title":"Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics","volume":"27","author":"Geerdink","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccc.2019.11.004_bib92","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41435-018-0030-3","article-title":"Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation","volume":"20","author":"Kernan","year":"2019","journal-title":"Genes Immun"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib93","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.ccc.2019.11.004_bib95","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib96","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/341940","article-title":"Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study","volume":"186","author":"Gerber","year":"2002","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib97","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib98","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","article-title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","volume":"89","author":"Greenbaum","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib99","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"16","key":"10.1016\/j.ccc.2019.11.004_bib101","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood-2013-11-516237","article-title":"How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib102","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5414\/CN107958","article-title":"Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis","volume":"82","author":"Povey","year":"2014","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib103","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfw453","article-title":"Eculizumab in secondary atypical haemolytic uraemic syndrome","volume":"32","author":"Cavero","year":"2017","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib104","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00467-003-1382-z","article-title":"Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia","volume":"19","author":"Cochran","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1016\/j.ccc.2019.11.004_bib105","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.inf.0000223494.83542.ad","article-title":"T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia","volume":"25","author":"Huang","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib106","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1515\/cclm-2014-0400","article-title":"The use of a rapid fluorogenic neuraminidase assay to differentiate acute Streptococcus pneumoniae-associated hemolytic uremic syndrome (HUS) from other forms of HUS","volume":"53","author":"Szilagyi","year":"2015","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib107","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpeds.2007.04.057","article-title":"Hemolytic uremic syndrome and streptococcus pneumoniae: improving our understanding","volume":"151","author":"Geary","year":"2007","journal-title":"J\u00a0Pediatr"},{"issue":"Pt 11","key":"10.1016\/j.ccc.2019.11.004_bib108","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1099\/jmm.0.063479-0","article-title":"Investigating the role of pneumococcal neuraminidase A activity in isolates from pneumococcal haemolytic uraemic syndrome","volume":"62","author":"Smith","year":"2013","journal-title":"J\u00a0Med Microbiol"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib109","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/jix305","article-title":"Streptococcus pneumoniae from patients with hemolytic uremic syndrome binds human plasminogen via the surface protein PspC and uses plasmin to damage human endothelial cells","volume":"217","author":"Meinel","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.ccc.2019.11.004_bib110","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ijmm.2018.08.007","article-title":"Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic concept","volume":"308","author":"Bitzan","year":"2018","journal-title":"Int J Med Microbiol"},{"issue":"9","key":"10.1016\/j.ccc.2019.11.004_bib111","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/ndt\/gft198","article-title":"The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome","volume":"28","author":"Szilagyi","year":"2013","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"10.1016\/j.ccc.2019.11.004_bib112","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/INF.0b013e3182191c58","article-title":"Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America","volume":"30","author":"Banerjee","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"4 Pt 1","key":"10.1016\/j.ccc.2019.11.004_bib113","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1542\/peds.101.4.699","article-title":"Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection","volume":"101","author":"Cabrera","year":"1998","journal-title":"Pediatrics"},{"issue":"3 Pt 1","key":"10.1016\/j.ccc.2019.11.004_bib114","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1542\/peds.102.3.538","article-title":"Three-year multicenter surveillance of systemic pneumococcal infections in children","volume":"102","author":"Kaplan","year":"1998","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib115","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1053\/ajkd.2001.21359","article-title":"Renal transplantation after Streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"37","author":"Krysan","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.ccc.2019.11.004_bib116","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00467-007-0518-y","article-title":"Streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"23","author":"Copelovitch","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib117","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00431-005-0041-8","article-title":"Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan","volume":"165","author":"Huang","year":"2006","journal-title":"Eur J Pediatr"},{"issue":"2 Pt 1","key":"10.1016\/j.ccc.2019.11.004_bib118","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.110.2.371","article-title":"Invasive pneumococcal disease and hemolytic uremic syndrome","volume":"110","author":"Brandt","year":"2002","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.ccc.2019.11.004_bib119","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12098-018-2620-5","article-title":"Streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"85","author":"Angurana","year":"2018","journal-title":"Indian J Pediatr"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1423-0410.1993.tb02532.x","article-title":"T-transformed red cells--role of minor cross-match in patients with T antigen activation","volume":"64","author":"Kumar","year":"1993","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib121","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1440-1797.2011.01500.x","article-title":"Invasive pneumococcal pneumonia is the major cause of paediatric haemolytic-uraemic syndrome in Taiwan","volume":"17","author":"Lee","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib122","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000045396","article-title":"Positive Coombs test in pneumococcus-associated hemolytic uremic syndrome. A review of the literature","volume":"82","author":"von Vigier","year":"1999","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib123","doi-asserted-by":"crossref","first-page":"F192","DOI":"10.1136\/fn.80.3.F192","article-title":"T\u00a0and Tk antigen activation in necrotising enterocolitis: manifestations, severity of illness, and effectiveness of testing","volume":"80","author":"Osborn","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib124","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jca.21208","article-title":"Therapeutic plasma exchange in Streptococcus pneumoniae-associated hemolytic uremic syndrome: a case report","volume":"27","author":"Petras","year":"2012","journal-title":"J\u00a0Clin Apher"},{"issue":"2","key":"10.1016\/j.ccc.2019.11.004_bib125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0009922815580406","article-title":"Streptococcus pneumoniae-associated hemolytic and uremic syndrome with cholestasis: a case report and brief literature review","volume":"55","author":"Anastaze Stelle","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib126","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib127","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.semnephrol.2017.05.010","article-title":"Acute kidney injury in pregnancy","volume":"37","author":"Jim","year":"2017","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib128","first-page":"641","article-title":"Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management","volume":"28","author":"De Sousa Amorim","year":"2015","journal-title":"J\u00a0Nephrol"},{"issue":"1","key":"10.1016\/j.ccc.2019.11.004_bib129","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-159-1-201307020-00023","article-title":"Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab","volume":"159","author":"Zschiedrich","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2 Pt 2","key":"10.1016\/j.ccc.2019.11.004_bib130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/AOG.0b013e31828e2612","article-title":"Eculizumab for atypical hemolytic uremic syndrome in pregnancy","volume":"122","author":"Ardissino","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"8415","key":"10.1016\/j.ccc.2019.11.004_bib131","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(84)90842-0","article-title":"Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient","volume":"2","author":"Bonser","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib132","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0272-6386(96)90468-0","article-title":"Cyclosporine-associated thrombotic microangiopathy\/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation","volume":"28","author":"Young","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.ccc.2019.11.004_bib133","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","article-title":"A\u00a0classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders","volume":"70","author":"Besbas","year":"2006","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.ccc.2019.11.004_bib134","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ccc.2019.11.004_bib135","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib136","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajh.23960","article-title":"Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin","volume":"90","author":"Reese","year":"2015","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib137","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"10.1016\/j.ccc.2019.11.004_bib138","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.ajkd.2017.05.023","article-title":"Quinine-induced thrombotic microangiopathy: a report of 19 patients","volume":"70","author":"Page","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"14","key":"10.1016\/j.ccc.2019.11.004_bib139","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N\u00a0Engl J Med"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070419300958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070419300958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:05:00Z","timestamp":1760061900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070419300958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0749070419300958"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2019.11.004","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}